Abstract:Streptococcus suis (S. suis) is one of the important pathogens that cause bacterial meningitis in pigs and humans. Evading host immune defences and penetrating the blood-brain barrier (BBB) are the preconditions for S. suis to cause meningitis, while the underlying mechanisms during these pathogenic processes are not fully understood. By detecting the red blood and white blood cells counts, IL-8 expression, and the pathological injury of brain in a mouse infection model, a serine-rich repeat (SRR) glycoprotein, designated as SssP1, was identified as a critical facilitator in the process of causing meningitis in this study. SssP1 was exported to assemble a fimbria-like component, thus contributed to the bacterial adhesion to and invasion into human brain microvascular endothelial cells (HBMECs), and activates the host inflammatory response during meningitis but is not involved in the actin cytoskeleton rearrangement and the disruption of tight junctions. Furthermore, the deletion of sssP1 significantly attenuates the ability of S. suis to traverse the BBB in vivo and in vitro. A pull-down analysis identified vimentin as the potential receptors of SssP1 during meningitis and following Far-Western blot results confirmed this ligand-receptor binding mediated by the NR2 (the second nonrepeat region) region of SssP1. The co-localisation of vimentin and S. suis observed by laser scanning confocal microscopy with multiplex fluorescence indicated that vimentin significantly enhances the interaction between SssP1 and BBB. Further study identified that the NR216-781 and NR1711-2214 fragments of SssP1 play critical roles to bind to the BBB depending on the sialylation of vimentin, and this binding is significantly attenuated when the antiserum of NR216-781 or NR1711-2214 blocked the bacterial cells, or the vimentin antibody blocked the BBB. Similar binding attenuations are observed when the bacterial cells were preincubated with the vimentin, or the BBB was preincubated with the recombinant protein NR216-781, NR1711-2214 or sialidase. In conclusion, these results reveal a novel receptor-ligand interaction that enhances adhesion to and penetration of the BBB to cause bacterial meningitis in the S. suis infection and highlight the importance of vimentin in host-pathogen interactions. Streptococcus suis (S. suis) is considered an important zoonotic pathogen capable of causing meningitis in humans. Penetrating the blood-brain barrier (BBB) is one of the preconditions for S. suis to cause meningitis, while its underlying mechanism is incompletely understood. Here we identified a previously uncharacterised pathogenic mechanism associated with S. suis meningitis mediated by the interaction between bacterial SRR glycoproteins and a host cytoskeletal component. During the bacterial infection, SRR protein SssP1 is exported to assemble a fimbria-like component, which drives a strong binding effect with the BBB depending on the sialylation of vimentin. This interaction contributes to the bacterial adhesion to and penetration of the BBB and induces a robust inflammatory response during meningitis. This overall observation underscores the significance of host cell surface vimentin interactions in microbial pathogenesis and markedly improves our understanding of host barrier penetration during meningitis.

Streptococcus Suis Small RNA Rss04 Contributes to the Induction of Meningitis by Regulating Capsule Synthesis and by Inducing Biofilm Formation in a Mouse Infection Model.

The Streptococcus Suis Transcriptional Landscape Reveals Adaptation Mechanisms in Pig Blood and Cerebrospinal Fluid

Roles of the Putative Type IV-like Secretion System Key Component VirD4 and PrsA in Pathogenesis of Streptococcus Suis Type 2.

Regulative synthesis of capsular polysaccharides in the pathogenesis of Streptococcus suis

SssP1, a Fimbria-like component of <i>Streptococcus suis</i>, binds to the vimentin of host cells and contributes to bacterial meningitis

A Streptococcus Suis LysM Domain Surface Protein Contributes to Bacterial Virulence.

Identification of an Autorepressing Two-Component Signaling System That Modulates Virulence in Streptococcus suis Serotype 2.

Advances in Pathogenesis of Streptococcus Suis Serotype 2

Interleukin-17A Contributed to the Damage of Blood-CNS Barriers During Streptococcus suis Meningitis

Comparative genomic analysis shows that Streptococcus suis meningitis isolate SC070731 contains a unique 105K genomic island.

The VraSR two-component signal transduction system contributes to the damage of blood-brain barrier during Streptococcus suis meningitis

The critical role of NLRP3 inflammasome activation in Streptococcus suis-induced blood-brain barrier disruption

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus Suis Biofilms in Meningitis in a Mouse Infection Model.

Ribosomal Protein SA-Positive Neutrophil Elicits Stronger Phagocytosis and Neutrophil Extracellular Trap Formation and Subdues Pro-Inflammatory Cytokine Secretion Against Streptococcus Suis Serotype 2 Infection

Streptococcus Suis 2 Transcriptional Regulator TstS Stimulates Cytokine Production and Bacteremia to Promote Streptococcal Toxic Shock-Like Syndrome

EGFR Transactivation Contributes to Neuroinflammation in Streptococcus Suis Meningitis.

Screening of Virulence-Related Transcriptional Regulators in Streptococcus suis

Insight into the role of Streptococcus suis zinc metalloprotease C from the new serotype causing meningitis in piglets

mRNA level of inflammation-associated cytokines of porcine alveolar macrophages cell lines 3D4/21 stimulated by Streptococcus suis serotype 2

The VraSR Regulatory System Contributes to Virulence in Streptococcus Suis Via Resistance to Innate Immune Defenses

Streptococcus Suis Uptakes Carbohydrate Source from Host Glycoproteins by N-glycans Degradation System for Optimal Survival and Full Virulence During Infection